You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Oral Presentations. Abstract session: RA - non biologic and small molecules
OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis

 

Online download statistics by month:

Online download statistics by month: June 2014 to February 2024

AbstractFullPdf
Jun 20141803
Jul 20141000
Aug 2014900
Sep 20141400
Oct 20141601
Nov 2014600
Dec 20141401
Jan 2015600
Feb 2015400
Mar 2015501
Apr 20151200
May 2015602
Jun 2015801
Jul 2015700
Aug 20151801
Sep 20152105
Oct 20151303
Nov 20151805
Dec 20151900
Jan 20162002
Feb 20161801
Mar 20162604
Apr 20161301
May 20162304
Jun 20161502
Jul 20161500
Aug 20162702
Sep 2016500
Oct 20162202
Nov 2016800
Dec 2016500
Jan 2017400
Feb 2017701
Mar 2017800
Apr 20171200
May 20171301
Jun 2017501
Jul 20173200
Aug 20171200
Sep 20172602
Oct 2017901
Nov 20171000
Dec 20171200
Jan 20181000
Feb 20181401
Mar 20181801
Apr 20181600
May 20182400
Jun 20181602
Jul 20182400
Aug 20183402
Sep 20181001
Nov 20181200
Dec 20182600
Jan 20191601
Feb 2019800
Mar 2019200
Apr 2019400
May 2019601
Jun 2019601
Jul 20191601
Aug 2019802
Oct 2019804
Dec 20191701
Jan 20201600
Feb 20202801
Mar 2020200
Jul 2020800
Aug 2020800
Sep 20202001
Oct 2020600
Nov 20202900
Dec 2020200
Jan 2021400
Mar 2021200
Apr 2021400
May 2021100
Jul 2021001
Oct 2021200
Nov 20211600
Dec 20211201
Jan 2022200
Feb 20221801
Apr 2022600
May 2022600
Jun 2022400
Jul 20221400
Aug 20221401
Sep 2022200
Oct 20221200
Nov 2022600
Dec 2022800
Jan 2023600
Feb 2023300
Mar 20231000
May 2023402
Jul 2023200
Aug 20231202
Sep 2023400
Oct 2023601
Nov 2023200
Dec 20231200
Jan 2024401
Feb 2024200
Total1185077